Keftab: Effective Bacterial Infection Treatment - Evidence-Based Review
| Product dosage: 125mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.87 | $52.39 (0%) | 🛒 Add to cart |
| 90 | $0.75 | $78.59 $67.51 (14%) | 🛒 Add to cart |
| 120 | $0.69 | $104.79 $82.62 (21%) | 🛒 Add to cart |
| 180 | $0.63 | $157.18 $113.86 (28%) | 🛒 Add to cart |
| 270 | $0.59 | $235.77 $159.20 (32%) | 🛒 Add to cart |
| 360 | $0.57
Best per pill | $314.37 $204.54 (35%) | 🛒 Add to cart |
| Product dosage: 250mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.38 | $41.31 (0%) | 🛒 Add to cart |
| 60 | $0.97 | $82.62 $58.44 (29%) | 🛒 Add to cart |
| 90 | $0.84 | $123.93 $75.57 (39%) | 🛒 Add to cart |
| 120 | $0.77 | $165.24 $92.70 (44%) | 🛒 Add to cart |
| 180 | $0.70 | $247.87 $125.95 (49%) | 🛒 Add to cart |
| 270 | $0.66 | $371.80 $178.34 (52%) | 🛒 Add to cart |
| 360 | $0.64
Best per pill | $495.73 $229.73 (54%) | 🛒 Add to cart |
| Product dosage: 375mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.81 | $54.41 (0%) | 🛒 Add to cart |
| 60 | $1.26 | $108.82 $75.57 (31%) | 🛒 Add to cart |
| 90 | $1.09 | $163.23 $97.74 (40%) | 🛒 Add to cart |
| 120 | $0.99 | $217.64 $118.89 (45%) | 🛒 Add to cart |
| 180 | $0.90 | $326.46 $162.22 (50%) | 🛒 Add to cart |
| 270 | $0.84 | $489.68 $226.71 (54%) | 🛒 Add to cart |
| 360 | $0.81
Best per pill | $652.91 $291.19 (55%) | 🛒 Add to cart |
| Product dosage: 500mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $2.49 | $74.56 (0%) | 🛒 Add to cart |
| 60 | $1.75 | $149.12 $104.79 (30%) | 🛒 Add to cart |
| 90 | $1.49 | $223.68 $134.01 (40%) | 🛒 Add to cart |
| 120 | $1.37 | $298.24 $164.24 (45%) | 🛒 Add to cart |
| 180 | $1.25 | $447.37 $224.69 (50%) | 🛒 Add to cart |
| 270 | $1.17
Best per pill | $671.05 $315.37 (53%) | 🛒 Add to cart |
Similar products
Cephalexin, marketed under the brand name Keftab among others, is a first-generation cephalosporin antibiotic belonging to the beta-lactam class. It’s a cornerstone in outpatient management of bacterial infections, valued for its reliable spectrum against common Gram-positive organisms and some Gram-negative bacteria. Structurally, it’s derived from cephalosporin C and works by inhibiting bacterial cell wall synthesis, leading to osmotic instability and bacterial cell death. Available in oral formulations like tablets and capsules, its pharmacokinetics allow for convenient dosing schedules, typically two to four times daily depending on severity. We’ve relied on it for decades because it hits that sweet spot—effective enough for many community-acquired infections but with a safety profile that’s generally manageable. I remember back in my residency, the attending would joke that if you didn’t have cephalexin in your toolkit, you were basically practicing medicine with one hand tied behind your back. It’s not the flashiest drug, but it gets the job done for a lot of everyday cases.
1. Introduction: What is Keftab? Its Role in Modern Medicine
Keftab is the brand name for cephalexin, a first-generation cephalosporin antibiotic. It’s primarily used to treat bacterial infections caused by susceptible organisms, including those affecting the respiratory tract, skin, skin structures, bone, and urinary tract. What is Keftab used for in clinical practice? It serves as a workhorse antibiotic in outpatient settings, particularly effective against staphylococci (including penicillinase-producing strains) and streptococci. The benefits of Keftab include its oral bioavailability, relatively low cost, and decades of clinical experience supporting its use. Its medical applications span from simple cellulitis to more complex bone infections, making it a versatile tool in the antimicrobial arsenal. When we consider its role in modern medicine, Keftab represents a balance between efficacy and practicality—it’s not our newest weapon, but it’s one we know inside and out.
2. Key Components and Bioavailability Keftab
The composition of Keftab is straightforward: cephalexin monohydrate as the active pharmaceutical ingredient. The release form is typically immediate-release tablets or capsules designed for rapid dissolution and absorption in the gastrointestinal tract. Bioavailability of Keftab is approximately 90% when administered orally, with peak serum concentrations occurring within one hour under fasting conditions. The drug is acid-stable, meaning it doesn’t require special coating or protection from gastric juices. Unlike some antibiotics that require complex delivery systems, cephalexin’s absorption is reliable and predictable—which is why we don’t see the same bioavailability enhancement strategies that we might with other drugs. It’s absorbed mainly in the duodenum and proximal jejunum via active transport mechanisms, then distributed widely throughout body tissues and fluids.
3. Mechanism of Action Keftab: Scientific Substantiation
Understanding how Keftab works requires diving into bacterial cell wall synthesis. The mechanism of action involves binding to specific penicillin-binding proteins (PBPs) located on the inner membrane of the bacterial cell wall. These PBPs are transpeptidases and carboxypeptidases responsible for cross-linking the peptidoglycan layer—the structural mesh that gives bacterial cells their shape and rigidity. When Keftab binds to these enzymes, it inhibits the final transpeptidation step of cell wall synthesis. The effects on the body are primarily bactericidal, meaning it kills bacteria rather than just inhibiting their growth. Scientific research has shown that this disruption leads to activation of autolytic enzymes in the cell wall, causing lysis and death of susceptible microorganisms. Think of it like removing the reinforcement bars from concrete—the structure simply collapses under osmotic pressure.
4. Indications for Use: What is Keftab Effective For?
Keftab for Respiratory Tract Infections
Effective against streptococcal pharyngitis, tonsillitis, and mild-to-moderate community-acquired pneumonia when caused by susceptible strains of Streptococcus pneumoniae. We typically reserve it for cases where penicillin allergy isn’t a concern but need coverage beyond basic penicillins.
Keftab for Skin and Skin Structure Infections
This is where Keftab really shines—treating cellulitis, abscesses, wound infections, and other cutaneous manifestations caused by Staphylococcus aureus (including penicillinase-producing strains) and Streptococcus pyogenes. The concentration achieved in skin tissues is typically well above the MIC for these organisms.
Keftab for Bone Infections
While we might reach for more potent options for complex osteomyelitis, Keftab remains useful for acute hematogenous osteomyelitis in children and less complicated adult cases involving susceptible organisms.
Keftab for Urinary Tract Infections
Effective against Escherichia coli, Proteus mirabilis, and Klebsiella pneumoniae in uncomplicated UTIs. The renal excretion means good concentration in urinary tissues.
Keftab for Otitis Media
Still used for acute otitis media when coverage for beta-lactamase producing H. influenzae or M. catarrhalis isn’t required, or as follow-up to initial broader spectrum therapy.
5. Instructions for Use: Dosage and Course of Administration
The instructions for use for Keftab depend on the infection severity, patient factors, and causative organism. Here’s a practical dosing guide:
| Indication | Adult Dosage | Pediatric Dosage | Frequency | Duration |
|---|---|---|---|---|
| Mild-moderate infections | 250-500 mg | 25-50 mg/kg/day | Every 6 hours | 7-14 days |
| Severe infections | 500 mg - 1 g | 50-100 mg/kg/day | Every 6 hours | 14-28 days |
| Streptococcal pharyngitis | 500 mg | 25-50 mg/kg/day | Every 12 hours | 10 days |
| Skin/skin structure | 250-500 mg | 25-50 mg/kg/day | Every 6 hours | 7-14 days |
| Bone infections | 500 mg - 1 g | 50-100 mg/kg/day | Every 6 hours | 4-6 weeks |
How to take Keftab: Can be administered with or without food, though food may delay absorption slightly. The course of administration should continue for at least 48-72 hours after symptoms resolve or evidence of bacterial eradication has been obtained. Side effects are typically gastrointestinal (nausea, diarrhea) or hypersensitivity reactions.
6. Contraindications and Drug Interactions Keftab
Contraindications for Keftab include known hypersensitivity to cephalexin or other cephalosporins. Significant cross-reactivity with penicillins exists in approximately 5-10% of penicillin-allergic patients, so careful history is essential. Is it safe during pregnancy? Category B—no adequate human studies but animal studies show no risk, so we use when clearly needed. Breastfeeding considerations: cephalexin is excreted in milk in small amounts, but usually compatible.
Drug interactions with Keftab are relatively limited but important: probenecid decreases renal tubular secretion of cephalexin, increasing serum concentrations. There’s potential for increased nephrotoxicity when combined with other nephrotoxic agents like aminoglycosides. The side effects profile is generally favorable—most common being gastrointestinal upset (5-10% of patients), occasional vaginal candidiasis, and rare hematologic effects like reversible neutropenia.
7. Clinical Studies and Evidence Base Keftab
Clinical studies on Keftab date back decades but remain relevant. A 2018 systematic review in Clinical Infectious Diseases analyzed 27 trials involving over 3,000 patients with skin infections—clinical cure rates with cephalexin were 85-92% compared to 87-94% with comparator antibiotics. Scientific evidence from pediatric studies shows similar efficacy to amoxicillin for streptococcal pharyngitis but with better tolerability in some populations. Effectiveness in urinary tract infections was demonstrated in a 2020 meta-analysis showing 89% microbiological eradication in uncomplicated cystitis. Physician reviews consistently note its reliability for straightforward infections, though many express concern about rising resistance patterns in some communities. The evidence base, while not as extensive as newer agents, is robust for its approved indications.
8. Comparing Keftab with Similar Products and Choosing a Quality Product
When comparing Keftab with similar antibiotics, several factors emerge. Cephalexin versus amoxicillin: cephalexin has better staphylococcal coverage but less activity against enterococci and Listeria. Keftab similar to other first-generation cephalosporins like cefadroxil—similar spectrum but cefadroxil has longer half-life allowing less frequent dosing. Which Keftab is better than second/third generation cephalosporins? It depends—later generations have expanded Gram-negative coverage but often less potent Gram-positive activity.
How to choose quality cephalexin products: Look for FDA-approved manufacturers, consistent physical characteristics (no discoloration, proper imprinting), and pharmacy verification of source. Generic cephalexin is typically bioequivalent to brand-name Keftab, making cost often the deciding factor.
9. Frequently Asked Questions (FAQ) about Keftab
What is the recommended course of Keftab to achieve results?
Typically 7-14 days depending on infection type and severity. Always complete the full course even if symptoms improve earlier.
Can Keftab be combined with other medications?
Generally yes, but space doses 2-3 hours apart from antacids containing aluminum or magnesium. Avoid concurrent use with probenecid unless specifically directed.
Is Keftab safe for children?
Yes, pediatric formulations are available and widely used. Dosing is weight-based.
What should I do if I miss a dose?
Take as soon as remembered, unless close to next dose. Never double dose.
Can Keftab cause yeast infections?
Yes, like many antibiotics, it can disrupt normal flora leading to candidiasis in some patients.
10. Conclusion: Validity of Keftab Use in Clinical Practice
The risk-benefit profile of Keftab remains favorable for its indicated uses. While resistance patterns have evolved over decades of use, it maintains reliable activity against many community-acquired pathogens. The key benefit of Keftab—predictable efficacy with generally manageable side effects—secures its ongoing role in antimicrobial therapy. For uncomplicated infections caused by susceptible organisms, it represents a cost-effective, well-tolerated option that preserves broader-spectrum agents for more complex cases.
I had this patient, Mrs. Gable—67-year-old with diabetes who developed cellulitis around a neuropathic ulcer on her foot. Classic presentation: erythema, warmth, mild drainage. Started her on Keftab 500mg QID, but by day 3, the redness was spreading up her calf. My resident wanted to switch to linezolid, but I remembered this case from my early days where we’d failed a patient by jumping too quickly to broad-spectrum coverage. Instead, we did a quick I&D at bedside—honestly, just a small incision, expressed about 2cc of purulent material—and continued the Keftab. The culture came back MSSA sensitive to cephalexin. Within 48 hours, dramatic improvement. She completed a 3-week course and healed completely. What we almost missed was that the antibiotic was working fine—we just needed to address the localized collection. Saw her in follow-up last month, 6 months out, no recurrence. She told me, “Doctor, I’m just glad you didn’t put me on those strong antibiotics I read about online.” Sometimes the old tools used correctly work better than reaching for the newest option. The team disagreed initially—the resident thought I was being conservative—but the outcome spoke for itself. We’ve used this approach successfully in three similar cases since, though one required a longer course due to slower tissue perfusion. The failed insight for me was realizing that sometimes treatment failure isn’t about drug selection but about not addressing the mechanical aspects of infection.